Skip to main content
Premium Trial:

Request an Annual Quote

Aussie Genomics Firm Licenses Junk-Gene Patents to Nanogen

NEW YORK, April 17 - Australian genomics company Genetic Technologies Group has given Nanogen a non-exclusive license to some of its gene patents.

 

Terms of the deal call for Nanogen to fork over about $620,000 in cash and securities in exchange for a number of patents GTG holds for certain non-coding, or junk, regions of human genes, GTG said yesterday.

 

The deal comes on the heels of a similar agreement with Sequenom worth roughly $537,000 signed last week.

 

GTG, a publicly traded company, is based in Melbourne.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.